STOCK TITAN

[Form 4] Palisade Bio, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Lemonade, Inc. (LMND) – Form 4 insider filing

CFO Timothy E. Bixby exercised 7,000 fully-vested employee stock options at an exercise price of $23.69, then sold the same 7,000 shares under a Rule 10b5-1 plan. The sales occurred on 18 Jul 2025 (6,000 sh. at $42.50) and 21 Jul 2025 (1,000 sh. at $42.70), generating gross proceeds of roughly $0.30 million versus an aggregate exercise cost of about $0.17 million.

After the transactions Mr. Bixby’s direct holding remains 263,393 common shares, unchanged from the level prior to the option exercises. He also retains 30,000 shares held indirectly through the Timothy E. Bixby Family Trust and 277,300 unexercised options expiring 25 Sep 2029.

The activity represents <0.02 % of LMND’s 67 million outstanding shares and appears routine portfolio diversification rather than a signal about business fundamentals. No other insiders transacted and no company cash was involved.

Lemonade, Inc. (LMND) – Comunicazione interna Form 4

Il CFO Timothy E. Bixby ha esercitato 7.000 opzioni azionarie per dipendenti completamente maturate al prezzo di esercizio di 23,69 dollari, vendendo successivamente le stesse 7.000 azioni tramite un piano Rule 10b5-1. Le vendite sono avvenute il 18 luglio 2025 (6.000 azioni a 42,50 dollari) e il 21 luglio 2025 (1.000 azioni a 42,70 dollari), generando un ricavo lordo di circa 0,30 milioni di dollari contro un costo complessivo di esercizio di circa 0,17 milioni di dollari.

Dopo queste operazioni, la detenzione diretta di Mr. Bixby rimane invariata a 263.393 azioni ordinarie, lo stesso livello precedente all’esercizio delle opzioni. Detiene inoltre 30.000 azioni indirettamente tramite il Timothy E. Bixby Family Trust e 277.300 opzioni non esercitate con scadenza il 25 settembre 2029.

L’attività rappresenta meno dello 0,02% delle 67 milioni di azioni in circolazione di LMND e sembra una normale diversificazione del portafoglio piuttosto che un segnale sui fondamentali aziendali. Nessun altro insider ha effettuato transazioni e non è stato coinvolto denaro aziendale.

Lemonade, Inc. (LMND) – Presentación interna Formulario 4

El CFO Timothy E. Bixby ejerció 7,000 opciones de acciones para empleados totalmente adquiridas a un precio de ejercicio de $23.69, y luego vendió las mismas 7,000 acciones bajo un plan Rule 10b5-1. Las ventas se realizaron el 18 de julio de 2025 (6,000 acciones a $42.50) y el 21 de julio de 2025 (1,000 acciones a $42.70), generando ingresos brutos de aproximadamente $0.30 millones frente a un costo total de ejercicio de cerca de $0.17 millones.

Tras las transacciones, la tenencia directa del Sr. Bixby permanece en 263,393 acciones ordinarias, sin cambios respecto al nivel previo al ejercicio de las opciones. También mantiene 30,000 acciones indirectamente a través del Timothy E. Bixby Family Trust y 277,300 opciones sin ejercer que vencen el 25 de septiembre de 2029.

La actividad representa menos del 0.02% de las 67 millones de acciones en circulación de LMND y parece ser una diversificación rutinaria de cartera más que una señal sobre los fundamentos del negocio. Ningún otro insider realizó transacciones y no se involucró dinero de la empresa.

Lemonade, Inc. (LMND) – 내부자 Form 4 신고

CFO Timothy E. Bixby는 행사 가격 $23.69에 완전히 취득된 직원 스톡옵션 7,000주를 행사한 후 Rule 10b5-1 계획에 따라 동일한 7,000주를 매도했습니다. 매도는 2025년 7월 18일(6,000주, 주당 $42.50)과 7월 21일(1,000주, 주당 $42.70)에 이루어졌으며, 총 매출액은 약 30만 달러, 행사 비용 총액은 약 17만 달러였습니다.

거래 후 Bixby 씨의 직접 보유 주식 수는 옵션 행사 전과 동일한 263,393주로 유지됩니다. 또한 Timothy E. Bixby 가족 신탁을 통해 간접 보유한 30,000주와 2029년 9월 25일 만료 예정인 미행사 옵션 277,300주를 보유하고 있습니다.

이번 거래는 LMND의 6,700만 발행 주식 중 0.02% 미만에 해당하며, 사업 기초체력에 대한 신호보다는 일상적인 포트폴리오 다각화로 보입니다. 다른 내부자는 거래하지 않았으며 회사 자금은 사용되지 않았습니다.

Lemonade, Inc. (LMND) – Déclaration d’initié Formulaire 4

Le CFO Timothy E. Bixby a exercé 7 000 options d’achat d’actions entièrement acquises au prix d’exercice de 23,69 $, puis a vendu ces mêmes 7 000 actions dans le cadre d’un plan Rule 10b5-1. Les ventes ont eu lieu les 18 juillet 2025 (6 000 actions à 42,50 $) et 21 juillet 2025 (1 000 actions à 42,70 $), générant un produit brut d’environ 0,30 million de dollars contre un coût d’exercice total d’environ 0,17 million de dollars.

Après ces opérations, la détention directe de M. Bixby reste inchangée à 263 393 actions ordinaires, au même niveau qu’avant l’exercice des options. Il détient également 30 000 actions indirectement via le Timothy E. Bixby Family Trust et 277 300 options non exercées arrivant à échéance le 25 septembre 2029.

Cette activité représente moins de 0,02 % des 67 millions d’actions en circulation de LMND et semble constituer une diversification de portefeuille de routine plutôt qu’un signal sur les fondamentaux de l’entreprise. Aucun autre initié n’a effectué de transaction et aucun fonds de la société n’a été impliqué.

Lemonade, Inc. (LMND) – Insider-Meldung Form 4

CFO Timothy E. Bixby hat 7.000 vollständig erworbene Mitarbeiteraktienoptionen zum Ausübungspreis von 23,69 US-Dollar ausgeübt und anschließend dieselben 7.000 Aktien im Rahmen eines Rule 10b5-1-Plans verkauft. Die Verkäufe erfolgten am 18. Juli 2025 (6.000 Aktien zu 42,50 US-Dollar) und am 21. Juli 2025 (1.000 Aktien zu 42,70 US-Dollar) und erzielten Bruttoerlöse von etwa 0,30 Millionen US-Dollar gegenüber Gesamtausübungskosten von rund 0,17 Millionen US-Dollar.

Nach den Transaktionen hält Herr Bixby unverändert 263.393 Stammaktien direkt, unverändert gegenüber dem Stand vor Ausübung der Optionen. Zudem besitzt er indirekt 30.000 Aktien über den Timothy E. Bixby Family Trust sowie 277.300 nicht ausgeübte Optionen mit Ablaufdatum 25. September 2029.

Die Aktivität entspricht weniger als 0,02 % der 67 Millionen ausstehenden LMND-Aktien und stellt eher eine routinemäßige Portfolio-Diversifikation als ein Signal für die Unternehmensgrundlagen dar. Keine weiteren Insider haben Transaktionen getätigt, und es wurden keine Unternehmensmittel verwendet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR – Small, routine 10b5-1 sale; immaterial to valuation.

The CFO merely swapped 7,000 options for stock, then liquidated the shares at a 79% spread to strike, netting about $131 k after costs. His ownership percentage and voting power are unchanged, and the sale represents a de minimis slice of the float. Option exercises marginally lower his remaining option pool, but there is no new dilution to shareholders because the exercised shares were already reserved. Given LMND’s multi-billion-dollar market cap, the transaction has no forecast or cash-flow impact and should not affect the investment thesis.

TL;DR – Filing shows good compliance; no red flags.

The transaction was executed under a pre-arranged Rule 10b5-1 plan, signalling procedural rigor and reducing the likelihood of informational abuse. The Form 4 was filed within the two-business-day window, and explanatory footnotes clearly outline the trust relationship and option status. Insider’s direct stake remains sizeable (> $11 m at current prices), aligning interests with shareholders. There are no patterns of accelerated selling or unusual derivatives activity. Overall governance implications are neutral to slightly positive.

Lemonade, Inc. (LMND) – Comunicazione interna Form 4

Il CFO Timothy E. Bixby ha esercitato 7.000 opzioni azionarie per dipendenti completamente maturate al prezzo di esercizio di 23,69 dollari, vendendo successivamente le stesse 7.000 azioni tramite un piano Rule 10b5-1. Le vendite sono avvenute il 18 luglio 2025 (6.000 azioni a 42,50 dollari) e il 21 luglio 2025 (1.000 azioni a 42,70 dollari), generando un ricavo lordo di circa 0,30 milioni di dollari contro un costo complessivo di esercizio di circa 0,17 milioni di dollari.

Dopo queste operazioni, la detenzione diretta di Mr. Bixby rimane invariata a 263.393 azioni ordinarie, lo stesso livello precedente all’esercizio delle opzioni. Detiene inoltre 30.000 azioni indirettamente tramite il Timothy E. Bixby Family Trust e 277.300 opzioni non esercitate con scadenza il 25 settembre 2029.

L’attività rappresenta meno dello 0,02% delle 67 milioni di azioni in circolazione di LMND e sembra una normale diversificazione del portafoglio piuttosto che un segnale sui fondamentali aziendali. Nessun altro insider ha effettuato transazioni e non è stato coinvolto denaro aziendale.

Lemonade, Inc. (LMND) – Presentación interna Formulario 4

El CFO Timothy E. Bixby ejerció 7,000 opciones de acciones para empleados totalmente adquiridas a un precio de ejercicio de $23.69, y luego vendió las mismas 7,000 acciones bajo un plan Rule 10b5-1. Las ventas se realizaron el 18 de julio de 2025 (6,000 acciones a $42.50) y el 21 de julio de 2025 (1,000 acciones a $42.70), generando ingresos brutos de aproximadamente $0.30 millones frente a un costo total de ejercicio de cerca de $0.17 millones.

Tras las transacciones, la tenencia directa del Sr. Bixby permanece en 263,393 acciones ordinarias, sin cambios respecto al nivel previo al ejercicio de las opciones. También mantiene 30,000 acciones indirectamente a través del Timothy E. Bixby Family Trust y 277,300 opciones sin ejercer que vencen el 25 de septiembre de 2029.

La actividad representa menos del 0.02% de las 67 millones de acciones en circulación de LMND y parece ser una diversificación rutinaria de cartera más que una señal sobre los fundamentos del negocio. Ningún otro insider realizó transacciones y no se involucró dinero de la empresa.

Lemonade, Inc. (LMND) – 내부자 Form 4 신고

CFO Timothy E. Bixby는 행사 가격 $23.69에 완전히 취득된 직원 스톡옵션 7,000주를 행사한 후 Rule 10b5-1 계획에 따라 동일한 7,000주를 매도했습니다. 매도는 2025년 7월 18일(6,000주, 주당 $42.50)과 7월 21일(1,000주, 주당 $42.70)에 이루어졌으며, 총 매출액은 약 30만 달러, 행사 비용 총액은 약 17만 달러였습니다.

거래 후 Bixby 씨의 직접 보유 주식 수는 옵션 행사 전과 동일한 263,393주로 유지됩니다. 또한 Timothy E. Bixby 가족 신탁을 통해 간접 보유한 30,000주와 2029년 9월 25일 만료 예정인 미행사 옵션 277,300주를 보유하고 있습니다.

이번 거래는 LMND의 6,700만 발행 주식 중 0.02% 미만에 해당하며, 사업 기초체력에 대한 신호보다는 일상적인 포트폴리오 다각화로 보입니다. 다른 내부자는 거래하지 않았으며 회사 자금은 사용되지 않았습니다.

Lemonade, Inc. (LMND) – Déclaration d’initié Formulaire 4

Le CFO Timothy E. Bixby a exercé 7 000 options d’achat d’actions entièrement acquises au prix d’exercice de 23,69 $, puis a vendu ces mêmes 7 000 actions dans le cadre d’un plan Rule 10b5-1. Les ventes ont eu lieu les 18 juillet 2025 (6 000 actions à 42,50 $) et 21 juillet 2025 (1 000 actions à 42,70 $), générant un produit brut d’environ 0,30 million de dollars contre un coût d’exercice total d’environ 0,17 million de dollars.

Après ces opérations, la détention directe de M. Bixby reste inchangée à 263 393 actions ordinaires, au même niveau qu’avant l’exercice des options. Il détient également 30 000 actions indirectement via le Timothy E. Bixby Family Trust et 277 300 options non exercées arrivant à échéance le 25 septembre 2029.

Cette activité représente moins de 0,02 % des 67 millions d’actions en circulation de LMND et semble constituer une diversification de portefeuille de routine plutôt qu’un signal sur les fondamentaux de l’entreprise. Aucun autre initié n’a effectué de transaction et aucun fonds de la société n’a été impliqué.

Lemonade, Inc. (LMND) – Insider-Meldung Form 4

CFO Timothy E. Bixby hat 7.000 vollständig erworbene Mitarbeiteraktienoptionen zum Ausübungspreis von 23,69 US-Dollar ausgeübt und anschließend dieselben 7.000 Aktien im Rahmen eines Rule 10b5-1-Plans verkauft. Die Verkäufe erfolgten am 18. Juli 2025 (6.000 Aktien zu 42,50 US-Dollar) und am 21. Juli 2025 (1.000 Aktien zu 42,70 US-Dollar) und erzielten Bruttoerlöse von etwa 0,30 Millionen US-Dollar gegenüber Gesamtausübungskosten von rund 0,17 Millionen US-Dollar.

Nach den Transaktionen hält Herr Bixby unverändert 263.393 Stammaktien direkt, unverändert gegenüber dem Stand vor Ausübung der Optionen. Zudem besitzt er indirekt 30.000 Aktien über den Timothy E. Bixby Family Trust sowie 277.300 nicht ausgeübte Optionen mit Ablaufdatum 25. September 2029.

Die Aktivität entspricht weniger als 0,02 % der 67 Millionen ausstehenden LMND-Aktien und stellt eher eine routinemäßige Portfolio-Diversifikation als ein Signal für die Unternehmensgrundlagen dar. Keine weiteren Insider haben Transaktionen getätigt, und es wurden keine Unternehmensmittel verwendet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Chuang Emil

(Last) (First) (Middle)
C/O PALISADE BIO, INC.
7750 EL CAMINO REAL, SUITE 2A

(Street)
CARLSBAD CA 92009

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PALISADE BIO, INC. [ PALI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $0.7502 07/18/2025 A 8,000 (1) 07/18/2035 Common Stock 8,000 $0 8,000 D
Explanation of Responses:
1. The option shall vest with respect to 8.33% of the underlying shares subject to the option in equal quarterly installments such that the option shall be fully vested on the three-year anniversary of July 18, 2025, subject to the reporting person's continued service as a member of the Issuer's Board of Directors through each applicable vesting date.
/s/ Emil Chuang 07/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Lemonade (LMND) shares did the CFO sell?

Timothy Bixby sold 7,000 common shares in two trades on 18 and 21 July 2025.

What was the average sale price for the insider transactions?

Shares were sold at $42.50 and $42.70, producing an average of roughly $42.53 per share.

Did the CFO’s overall ownership in LMND change after the Form 4 transactions?

No. Direct holdings remain 263,393 shares; 30,000 indirect trust shares are unchanged.

Were the sales executed under a Rule 10b5-1 trading plan?

Yes, the footnotes state the sales were made pursuant to a Rule 10b5-1 plan adopted 12 Dec 2024.

How many options does the CFO still hold after the exercises?

Mr. Bixby retains 277,300 unexercised stock options expiring 25 Sep 2029.
Palisade Bio Inc

NASDAQ:PALI

PALI Rankings

PALI Latest News

PALI Latest SEC Filings

PALI Stock Data

3.75M
4.77M
0.8%
7.2%
4.99%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
CARLSBAD